TRIB2 and cancer: The results of an MTT assay, which was performed to clarify the role of TRIB2 in cancer progression, showed that TRIB2 knockdown inhibited the proliferation of A549 cells (Figure 1F), whereas TRIB2 overexpression promoted the proliferation of A549 cells (Figure 1G).